MTEMQ — Molecular Templates Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$9.66m
- $57.31m
Brief: Molecular Templates Reports Third Quarter 2021 Financial Results
Molecular Templates Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Molecular Templates Inc Says On Oct 15, Co Received Termination Notice From Vertex Pharmaceuticals
Molecular Templates Inc reports results for the quarter ended in June - Earnings Summary
Brief: Molecular Templates, Inc. Reports Second Quarter 2021 Financial Results
Molecular Templates Inc expected to post a loss of 28 cents a share - Earnings Preview
Molecular Templates Inc expected to post a loss of 28 cents a share - Earnings Preview
Molecular Templates Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Molecular Templates, Inc. Announces Dosing Of First Subject In Phase 1 Study Of MT-6402 In Pd-L1-Positive Solid Tumors
Brief: RapidPulse Launches With $15 Mln Series A Financing
Brief: Molecular Templates Inc CFO Adam Cutler Informed Co Of His Intent To Resign
Molecular Templates Inc reports results for the quarter ended in March - Earnings Summary
Brief: Molecular Templates, Inc. Reports First Quarter 2021 Financial Results
Molecular Templates Inc expected to post earnings of 14 cents a share - Earnings Preview
Molecular Templates Inc expected to post earnings of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Alphabet Inc, AMC Entertainment, oil stocks, cruise stocks
Molecular Templates: Down after development of lead cancer therapy scrapped
Brief: Molecular Templates Inc Says To Prioritize Next-Generation Etb Candidates
Brief: Molecular Templates Inc Reports Q4 Loss Per Share Of $0.57